#
#
» Industry symposia

Industry symposia

 


Wednesday, April 9

12:45-13:15
CeloNova Bio Science
 
Bland Embolization for Liver Tumors with the
Novel 40 Micron EmbozeneTM Microsphere

F. Orsi (Milan/IT)
 


Thursday, April 10

  

12:00-12:30
Bayer Healthcare

   
Nexavar: The New Treatment Paradigm in Hepatocellular Carcinoma
Chair: Riccardo Lencioni (Pisa/IT)

New hope for unmet needs in advanced and recurrent hepatocellular carcinoma (HCC)
J. Bruix (Barcelona/ES)
Nexavar as the standard of care in HCC: implications for earlier stages in HCC and future directions
J.M. Llovet (Barcelona/ES)
 
12:30 - 13:15 Terumo/Biocompatibles
   
 
   
Infarction endpoint in bland embolization and drug eluting beads: latest updates
Chair: A. Denys (Lausanne/CH)

UFE treatment: long-term follow up of bead block registry
T.J. Kröncke (Berlin/DE)
TACE with DC beads as a pretransplant treatment for HCC: results with anatomopathological data
P. Goffette (Brussels/BE)
International hepatic arterial embolization registry of malignant tumours
R. Martin (US)
 
13:15 - 14:00
Angiodynamics
 
Innovations in embolization and radio frequency ablation

Drug-eluting bead-enhanced RF ablation of liver cancer
R. Lencioni (Pisa/IT)
Latest Optimization Updates of Radio Frequency Ablation lectrodes
L. Appelbaum (Jerusalem/IL)

 

 















 



 Back  print page  Top
GEST 2009 is kindly supported by:

Copyright © CIRSE Foundation (Cardiovascular and Interventional Radiological Society of Europe)